Mechanisms of neuromuscular junction formation

神经肌肉接头形成机制

基本信息

  • 批准号:
    10267688
  • 负责人:
  • 金额:
    $ 56.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

The neuromuscular junction (NMJ), a synapse formed between motoneurons and muscle fibers, has contributed greatly to understanding of the general principles of synaptogenesis, as well as of neuromuscular disorders. NMJ formation requires intimate interaction between motoneurons and muscle fibers. For example, in antegrade signaling, motoneurons release agrin that binds LRP4, a member of the LDL receptor family, in muscle cells to activate the receptor tyrosine kinase MuSK, both of which are required for NMJ formation. Downstream of MuSK was not well understood, except that AChR concentration absolutely requires the adapter protein rapsyn. However, exactly how signals are transduced from MuSK activation to AChR concentration is not well understood. On the other hand, skeletal muscles are known to be critical to the development of axon terminals of motoneurons. In contrast to antegrade regulation, much less is understood about molecular mechanisms of retrograde regulation of presynaptic differentiation by muscle fibers. In preliminary studies, we discovered that the classic adaptor protein rapsyn is an E3 ligase. Knockin mice carrying the mutation of a single residue necessary for the enzymatic activity are unable to form the NMJ. Our results suggest that rapsyn contributes to AChR clustering by promoting neddylation. These observations identify a previously unappreciated enzymatic activity of rapsyn and a role of neddylation in synapse formation. Our studies of LRP4 suggest that it could regulate developing axons by mechanisms independent of MuSK. The proposal will test two hypotheses. First, MuSK increases rapsyn enzyme activity to promote neddylation for AChR clustering and NMJ formation. Second, muscle regulates presynaptic differentiation via LRP4. Results of this proposal will provide a better understanding of cellular as well as molecular mechanisms of mammalian NMJ formation and contribute to a better understanding of pathogenic mechanisms of neuromuscular disorders.
神经肌肉接头(NMJ)是运动神经元和肌纤维之间形成的突触, 对理解突触发生的一般原理以及 神经肌肉疾病。NMJ的形成需要运动神经元之间的密切相互作用 和肌肉纤维。例如,在顺行信号中,运动神经元释放结合的集聚蛋白。 LRP4,低密度脂蛋白受体家族的成员,在肌肉细胞中激活受体酪氨酸 激酶麝香,两者都是形成NMJ所必需的。马斯克下游的情况不太好 了解,除非AChR的浓度绝对需要接头蛋白Rapsyn。 然而,信号是如何从麝香激活传递到AChR浓度的,目前还不清楚 很好理解。另一方面,骨骼肌被认为是发育的关键。 运动神经元的轴突终末。与顺行监管相比,人们理解的要少得多 肌肉逆行调节突触前分化的分子机制 纤维。在初步研究中,我们发现经典的接头蛋白Rapsyn是一个E3 连接酶。Knockin小鼠携带酶所必需的单一残基突变 活动无法形成NMJ。我们的结果表明Rapsyn在AChR中起作用 通过促进新陈代谢来实现集群。这些观察发现了一种以前没有被认识到的 Rapsyn的酶活性及其在突触形成中的作用。我们对LRP4的研究 这表明它可以通过独立于马斯克的机制来调节发育中的轴突。这个 该提案将检验两个假设。首先,麝香增加Rapsyn酶的活性以促进 AChR聚集和NMJ形成的关系。第二,肌肉调节突触前 通过LRP4进行分化。这项提案的结果将使您更好地理解蜂窝AS 以及哺乳动物NMJ形成的分子机制,并有助于更好地 了解神经肌肉疾病的发病机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WEN-CHENG XIONG其他文献

WEN-CHENG XIONG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WEN-CHENG XIONG', 18)}}的其他基金

Skeletal Muscular Swedish Mutant APP in Alzheimer's Disease Development
瑞典骨骼肌突变体 APP 在阿尔茨海默病发展中的作用
  • 批准号:
    10254624
  • 财政年份:
    2021
  • 资助金额:
    $ 56.87万
  • 项目类别:
Skeletal Muscular Swedish Mutant APP in Alzheimer's Disease Development
瑞典骨骼肌突变体 APP 在阿尔茨海默病发展中的作用
  • 批准号:
    10513298
  • 财政年份:
    2021
  • 资助金额:
    $ 56.87万
  • 项目类别:
Retromer deficiency and Alzheimer's disease pathology
逆转录酶缺乏与阿尔茨海默病病理学
  • 批准号:
    9605932
  • 财政年份:
    2017
  • 资助金额:
    $ 56.87万
  • 项目类别:
APP as a common denominator for Alzheimer's disease and osteoporosis
APP 是阿尔茨海默病和骨质疏松症的共同点
  • 批准号:
    9903240
  • 财政年份:
    2016
  • 资助金额:
    $ 56.87万
  • 项目类别:
APP as a common denominator for Alzheimer's disease and osteoporosis
APP 是阿尔茨海默病和骨质疏松症的共同点
  • 批准号:
    9607371
  • 财政年份:
    2016
  • 资助金额:
    $ 56.87万
  • 项目类别:
APP as a common denominator for Alzheimer's disease and osteoporosis
APP 是阿尔茨海默病和骨质疏松症的共同点
  • 批准号:
    9323223
  • 财政年份:
    2016
  • 资助金额:
    $ 56.87万
  • 项目类别:
Retromer deficiency and Alzheimer's disease pathology
逆转录酶缺乏与阿尔茨海默病病理学
  • 批准号:
    9059562
  • 财政年份:
    2014
  • 资助金额:
    $ 56.87万
  • 项目类别:
Retromer deficiency and Alzheimer's disease pathology
逆转录酶缺乏与阿尔茨海默病病理学
  • 批准号:
    9486649
  • 财政年份:
    2014
  • 资助金额:
    $ 56.87万
  • 项目类别:
Retromer deficiency and Alzheimer's disease pathology
逆转录酶缺乏与阿尔茨海默病病理学
  • 批准号:
    8842912
  • 财政年份:
    2014
  • 资助金额:
    $ 56.87万
  • 项目类别:
Retromer deficiency and Alzheimer's disease pathology
逆转录酶缺乏与阿尔茨海默病病理学
  • 批准号:
    8708256
  • 财政年份:
    2014
  • 资助金额:
    $ 56.87万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 56.87万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.87万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 56.87万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.87万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 56.87万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.87万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 56.87万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 56.87万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 56.87万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.87万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了